(Q40372462)

19 September 2017

1 reference

title

3D-QSAR: a current perspective (English)

1 reference

ORCID Public Data File 2021

19 September 2017

1 reference

author name string

Green SM

series ordinal

1

1 reference

19 September 2017

Marshall GR

series ordinal

2

1 reference

19 September 2017

publication date

1 September 1995

1 reference

Trends in Pharmacological Sciences

19 September 2017

published in

1 reference

19 September 2017

volume

16

1 reference

19 September 2017

issue

9

1 reference

19 September 2017

page(s)

285-291

1 reference

Three-dimensional structure-activity relationships

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Mechanisms of intron mobility.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Derivation of a 3D pharmacophore model for the angiotensin-II site one receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Three-dimensional quantitative structure-activity relationship of human immunodeficiency virus (I) protease inhibitors. 2. Predictive power using limited exploration of alternate binding modes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Direct prediction of dissociation constants (pKa's) of clonidine-like imidazolines, 2-substituted imidazoles, and 1-methyl-2-substituted-imidazoles from 3D structures using a comparative molecular field analysis (CoMFA) approach

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Nonlinear dependence in comparative molecular field analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

The use of the GRID program in the 3-D QSAR analysis of a series of calcium-channel agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog a

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

HINT: a new method of empirical hydrophobic field calculation for CoMFA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Structural determinants of high-affinity binding of ryanoids to the vertebrate skeletal muscle ryanodine receptor: a comparative molecular field analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Molecular lipophilicity potential, a tool in 3D QSAR: method and applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Structure-activity relationships from molecular similarity matrices.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Predictive ability of regression models. Part I: Standard deviation of prediction errors (SDEP)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

D-Optimal Designs in QSAR

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D-QSAR Problems

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Comparative Molecular Field Analysis Using GRID Force-Field and GOLPE Variable Selection Methods in a Study of Inhibitors of Glycogen Phosphorylase b

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Distance geometry approach to rationalizing binding data

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Analysis of the in vitro antiviral activity of certain ribonucleosides against parainfluenza virus using a novel computer aided receptor modeling procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Mapping the binding site of the nucleoside transporter protein: a 3D-OSAR study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Genetically evolved receptor models: a computational approach to construction of receptor models.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

Three-dimensional pharmacophores from binding data

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

An application of 3D-QSAR to the analysis of the sequence specificity of DNA alkylation by uracil mustard

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

The computer program LUDI: a new method for the de novo design of enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

GroupBuild: a fragment-based method for de novo drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2989052-5

7 January 2021

10.1016/S0165-6147(00)89052-5

Identifiers

DOI

1 reference

19 September 2017

1 reference